• drug craving and physiological arousal (heart rate, skin conductance, blood pressure) during cue exposure session [ Time Frame: during initial cue exposure session (same day as drug administration) ] [ Designated as safety issue: No ]
  

• drug craving and physiologic arousal (heart rate, skin conductance, blood pressure) during cue exposure session [ Time Frame: at one-week follow-up assessment (one week after drug administration) ] [ Designated as safety issue: No ]
  
• amount of cocaine use (in dollars) in days between the testing visit and the one week follow-up visit [ Time Frame: measured at one-week follow-up visit ] [ Designated as safety issue: No ]
  The amount of cocaine used between the testing visit and the one-week follow-up visit will be recorded using dollar amounts to preliminarily evaluate group differences in cocaine use.
  
  

This study will employ cocaine-dependent individuals to investigate the acute effects of propranolol vs. placebo, administered immediately after a retrieval session of cocaine cue exposure, on the subjective and physiological responses occurring during a subsequent test session of cocaine cue exposure. Participants (N=52) will be randomly assigned to receive 40 mg propranolol or placebo immediately after the first of two cocaine cue exposure sessions scheduled to occur on consecutive days of an inpatient stay at MUSC's General Clinical Research Center (GCRC). The first session will serve as a retrieval session where cocaine cue exposure will putatively elicit retrieval and reconsolidation of memories about the association between the cues and cocaine administration; the second session of cocaine cue exposure will be a test session to examine the potential modulatory role of propranolol on the reconsolidated memories putatively elicited during the previous cue exposure session. It is assumed that changes in craving and physiological reactivity during the test session will reflect propranolol's effects on memory reconsolidation processes elicited by cue exposure during the retrieval session. Medications will be administered in a double-blind fashion. Craving and physiological arousal (heart rate, skin conductance, blood pressure) will be obtained at baseline and at regular intervals during and after both cue exposure sessions. Approximately 7 days following discharge from the inpatient stay at the GCRC, participants will return to the GCRC to undergo a 1-week follow-up cue exposure session that will be identical to the previous two sessions (no medications will be administered). The goal of the follow-up will be to examine if any craving and/or physiological reactivity differences identified during the test session were sustained and to assess if the groups differed in their cocaine use during the intervening 7-day period.